glp 1 women's health GLP-1s for Weight Loss: What You Need to Know among others Stay Strong on a GLP-1

In Compounded topical pain creams: Review of select ingredients for safety, effectiveness, and use

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

The STEP 1 clinical trial, published in The New England Journal of Medicine , enrolled nearly 2,000 adults with overweight or obesity and found that participants using semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks

Hims & Hers also includes educational content on managing side effects and maximizing results from GLP-1 treatment